Uric acid: what it proves, and what it only suggests

For about a century, uric acid was the gout number — checked when a big toe swelled, ignored otherwise. Then the metabolic-health world rediscovered it: bestselling books argue it quietly drives obesity and blood pressure, longevity podcasts treat it as a dashboard metric, and “optimal” targets a full two points below the lab range circulate as settled fact.

Here’s the honest version: uric acid is one of the best-documented markers of metabolic trouble in your blood — and one of the least proven causes of it. Both halves of that sentence matter, they lead to different decisions, and most pages ranking for this search tell you only one of them. This page keeps them separate.

What uric acid is

Uric acid is the end product of purine metabolism — purines being building blocks of DNA and RNA that your body recycles constantly and that also arrive in food. Most mammals break uric acid down further with an enzyme called uricase; humans lost that enzyme long ago, so our levels run high by mammal standards and sit close to the chemical ceiling. About two-thirds of your urate leaves through the kidneys, the rest through the gut — which is why kidney function silently co-writes this number.

The proven part: gout and kidney stones

This part isn’t debated. Above roughly 6.8 mg/dL, urate exceeds its physical solubility in body fluids and can crystallize — in joints (gout) and in urine (uric acid kidney stones). Gout is the most common inflammatory arthritis in adults, it is excruciating, and it is one of the few conditions in medicine we can treat almost to abolition: for people with diagnosed gout, guidelines set a treat-to-target level of below 6.0 mg/dL with urate-lowering medication, and flares stop when the target holds.

So if you have joint attacks, a stone history, or a strong family history of either, this number stops being philosophical. Roughly one in five U.S. adults has a uric acid above the solubility line; most will never develop gout — but the ones who do usually saw the number first.

The debated part: metabolic marker, or metabolic cause?

Now the half the internet argues about. In observational studies, higher uric acid tracks with nearly everything you don’t want: hypertension, insulin resistance, metabolic syndrome, chronic kidney disease, cardiovascular events, earlier death. The associations are real, graded, and remarkably consistent. The question is direction: does uric acid drive that damage, or does it ride along with the things that do — insulin resistance, excess fructose, declining kidneys?

The best evidence we have for the causal question says: probably mostly riding along.

• Genetics: Mendelian randomization studies — which use inherited urate-raising gene variants as a natural experiment — largely fail to show that lifelong higher urate causes heart attacks or strokes.
• Trials: ALL-HEART (2022), a large randomized trial adding allopurinol (a urate-lowering drug) to usual care in people with ischemic heart disease, found no cardiovascular benefit.
• Guidelines: the American College of Rheumatology recommends against urate-lowering medication for people with high uric acid and no gout — there’s no trial evidence it helps them.

Plain summary: a high uric acid reliably marks metabolic trouble; that lowering the number treats the trouble is unproven. If your uric acid is high and you feel fine, the evidence points at investigating why — the insulin, the fructose, the kidneys, the beer — not at medicating the number.

The zeitgeist, handled fairly

The fructose–urate hypothesis deserves a fair sentence, because it isn’t quackery. Fructose is metabolically unusual: its breakdown in the liver consumes ATP in a way that generates urate directly, and serious researchers have proposed urate as an active switch in fat storage and blood pressure — with real mechanistic and animal work behind it. It is a genuine scientific hypothesis. It is also still a hypothesis: the human trials that would confirm it haven’t. Watching your uric acid as an early metabolic signal is reasonable and cheap. Expecting a lower number to prevent heart disease outruns what anyone has shown.

What moves uric acid that isn’t disease

The house rule: every marker gets its confounder list, because a number that jumps has usually met one of these before it’s met a disease.

• Fasting, keto, and rapid weight loss — all raise uric acid (ketones compete with urate for kidney excretion). A high reading mid-diet or after a long fast is expected, not alarming — and worth retesting once things stabilize.
• Alcohol — raises it through production and blocked excretion; beer is the worst offender (it brings its own purines).
• Common medications — thiazide and loop diuretics, low-dose aspirin, and niacin each raise urate.
• Dehydration — concentrates it; the pre-draw glass of water is legal and fine.
• Purine-heavy meals — organ meats and some seafood (sardines, anchovies, shellfish) push it up transiently.
• Sugary drinks and fructose — raise it by the mechanism above, whatever that mechanism ultimately proves to cause.
• Your kidneys themselves — since two-thirds of urate exits renally, declining filtration raises uric acid with no change in production. A rising urate alongside a falling cystatin C–based eGFR is a kidney story, not a purine story.

And a difference that’s biology, not cosmetics: premenopausal women run roughly 1 mg/dL lower than men (estrogen helps the kidneys excrete urate), which is why honest reference ranges are sex-specific — and why a “6.2” means different things in different people.

What the ranges honestly look like

Serum urate in mg/dL. Lab-flagged “high” typically starts around 7.0–7.2 for men and 5.7–6.0 for women (varies by lab); 6.8 is the physical solubility line regardless of who you are.

No guideline endorses treating the number itself in someone without gout or stones — what a physician actually reads is the trend, the context, and the company the number keeps.

Why it earns its place on a whole-body panel

Uric acid is cheap, old, and unglamorous — and almost uninterpretable alone, which is exactly why it belongs next to its context. High insulin makes the kidneys hold on to urate, so uric acid often rises with fasting insulin years before HbA1c budges — read together, they’re an early metabolic pattern; read alone, urate is just a scary red flag. Falling kidney filtration raises it mechanically, so it can’t be read without the cystatin C picture. And because urate crystals are inflammatory, it sits meaningfully beside hs-CRP — our panel lists it under both metabolic health and inflammation for that reason. The markers annotate each other, if someone actually reads them together.

How to get your uric acid tested

1. Through your doctor — routinely ordered with gout symptoms, stones, or on diuretics; usually covered in those contexts.
2. Order it a la carte. About $16 all-in from discount online labs (verified August 2026) — genuinely one of the cheapest tests on the DTC shelf. Workable; but a solo urate without the insulin, kidney, and inflammation context is precisely the orphan number this page warns about, on the marker where context is most of the meaning.
3. Measure it inside a full panel a physician actually reads. Terve Health is a whole-body panel — drawn once at any of 2,000+ Quest locations, ordered by a licensed clinician, and returned as a written plain-language review: your urate read against your insulin, your kidney estimates, your inflammation markers, and last year’s trend. You don’t choose a panel — a physician orders the right one for you. And if a result deserves real follow-up, the medical practice behind your panel can actually see you.

Uric acid and the rest of the picture

• Fasting insulin — high insulin reduces urate excretion; the pair often moves first in metabolic drift.
• HbA1c — the later-moving glucose verdict; urate frequently stirs earlier.
• Cystatin C — the kidney context two-thirds of this number depends on.
• hs-CRP — the inflammation neighbor; urate crystals are one of inflammation’s oldest triggers.

Browse the full biomarker library to see everything the panel covers.

Frequently asked questions

What is a normal — or optimal — uric acid level? Lab-normal runs up to about 7.0–7.2 mg/dL for men and 5.7–6.0 for women. Cohort studies associate the lowest cardiometabolic risk with values roughly in the 3.5–5.5 range — but that’s an association, not a proven target, and no guideline tells healthy people to medicate toward it. For diagnosed gout, the target is real: below 6.0.

Is high uric acid dangerous if I feel fine? Above ~6.8 mg/dL, crystals can form — but most people above that line never develop gout. The better way to hear a high result while feeling fine: it’s a question, usually about insulin, alcohol, fructose, medications, or kidney function. The evidence supports investigating those; it does not support treating the number itself in someone without gout or stones.

Does high uric acid cause heart disease? It predicts it in observational studies — consistently. But genetic studies mostly fail to show causation, and a large trial of urate-lowering medication in heart-disease patients (ALL-HEART, 2022) found no cardiovascular benefit. Honest answer: uric acid is a useful warning light on the metabolic dashboard; nobody has shown that unplugging the light fixes the engine.

How do I lower uric acid? The levers with the least regret are the ones worth pulling anyway: weight loss (slowly — crash dieting transiently raises urate), fewer sugary drinks, less alcohol (especially beer), decent hydration. Medication is for diagnosed gout and stones, per guidelines — where it works superbly — not for a number on a screening panel.

Why is my uric acid high on keto or after fasting? Ketones and urate compete for the same exit in the kidney, so ketosis, extended fasting, and rapid weight loss all push uric acid up — commonly and expectedly. It usually settles as your weight and diet stabilize; a repeat under normal conditions beats a conclusion drawn mid-diet.

Sources

1. Kuwabara M, et al. The optimal range of serum uric acid for cardiometabolic diseases: a 5-year Japanese cohort study. J Clin Med. 2020. (Cohort-derived lowest-risk range.)
2. FitzGerald JD, et al. 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Care Res. 2020. (Treat-to-target <6.0 for gout; conditional recommendation against urate-lowering therapy for asymptomatic hyperuricemia.)
3. Mackenzie IS, et al. Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial. Lancet. 2022. (No cardiovascular benefit.)
4. Efstathiadou A, et al. Genetically determined uric acid and the risk of cardiovascular and neurovascular diseases: a Mendelian randomization study. J Am Heart Assoc. 2019. (Causality largely unsupported for cardiovascular outcomes.)
5. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008. (The association evidence and the causal hypothesis, from the hypothesis’s own leading proponents.)
6. Johnson RJ, et al. Sugar, uric acid, and the etiology of diabetes and obesity. Diabetes. 2013. (The fructose–urate hypothesis — cited here as hypothesis.)
7. Chen-Xu M, et al. Contemporary prevalence of gout and hyperuricemia in the United States: NHANES 2015–2016. Arthritis Rheumatol. 2019. (~1 in 5 adults with hyperuricemia.)

Terve Health measures and helps you understand your biomarkers; it does not diagnose, treat, or prevent disease. Laboratory testing performed by Quest Diagnostics®; testing is ordered and results are reviewed by licensed clinicians at an independent medical practice. Always discuss results and treatment with a licensed clinician.